Spotlight reflected on the results from two TB trials - SimpliciTB and TRUNCATE-TB, reported at the 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) held on 19-22 February 2023 in Seattle, Washington, USA, featuring TAG TB Co-Director Lindsay McKenna, elaborating on what comes next as an alternative to the six-month drug-susceptible standard of TB care.
Read the full article here.